ADVERTISEMENT
Manila Bulletin devider Philippines devider National devider FDA: Only 242 fully vaccinated people experience 'breakthrough' COVID-19 infection

FDA: Only 242 fully vaccinated people experience 'breakthrough' COVID-19 infection

Published Sep 9, 2021 02:51 pm

FDA

The Food and Drug Administration (FDA) said that only 242 fully vaccinated individuals against coronavirus disease (COVID-19) in the country experienced “breakthrough infections” out of millions of Filipinos who completed the regimen.

FDA Director-General Rolando Enrique Domingo said that the figure is only equivalent to 0.0017 percent of the 13.8 million Filipinos fully vaccinated against COVID-19 as of Aug. 29.

"We can say that the benefits of the vaccination outweigh the risks and the vaccines are effective and critical to controlling the COVID-19 pandemic," said Domingo in a press briefing on Thursday, Sept. 9.

Domingo defined breakthrough infection as "detection of the disease in a person more than 14 days after completion of all the recommended doses of COVID-19 vaccines."

FDA data showed that 180 out of the 6.86 million people vaccinated with Sinovac contracted COVID-19. Of the 180 breakthrough cases, four died. Meanwhile, 11 out of the 3.56 million who received the single-shot Janssen vaccine caught the viral illness. Of the 11, one died.

The five deaths involved senior citizens and some of them have comorbidities, said the FDA chief.

Forty-seven people of the 2.03 million who received AstraZeneca vaccines were infected with COVID-19, while four people out of 1.23 million who were vaccinated with Pfizer vaccine got breakthrough infection.

There was no record of breakthrough infections among people inoculated with Sputnik V, Moderna, and Sinopharm vaccines, said Domingo.

"Breakthrough infections can still occur in a small percentage of fully vaccinated individuals," he said.

Other infections

The FDA chief also reported that out of 9.22 million individuals who were partially vaccinated as of Aug. 29, a total of 732 people got COVID-19, including 86 deaths.

Meanwhile, 98 people contracted COVID-19 "within 14 days" after receiving their last dose. Of the 98 cases, five died.

Despite this, Domingo urged the vaccinated individuals to "complete the recommended doses" of COVID-19 vaccines.

"Observe health protocols, maximum protection sets in two weeks after the second shot," said Domingo.

“Magpabakuna po tayo kapag tayo ay eligible na upang maprotektahan natin ang ating sarili at pamilya laban sa COVID-19. Itong datos na nakalap ng FDA ay nagpapakita na safe at effective po ang ating mga bakunang may Emergency Use Authorization (Let's get vaccinated when we are eligible so that we can protect ourselves and our families against COVID-19. This data gathered by the FDA shows that vaccines with Emergency Use Authorization are safe and effective)," he added.

Related Tags

breakthrough infections Food and Drug Administration covid-19 vaccine
ADVERTISEMENT
.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1561_widget.title }}

{{ item.title }}
.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1562_widget.title }}

{{ item.title }}
.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1563_widget.title }}

{{ item.title }}

{{ articles_filter_1564_widget.title }}

{{ item.title }}
.mb-article-details { position: relative; } .mb-article-details .article-body-preview, .mb-article-details .article-body-summary{ font-size: 17px; line-height: 30px; font-family: "Libre Caslon Text", serif; color: #000; } .mb-article-details .article-body-preview iframe , .mb-article-details .article-body-summary iframe{ width: 100%; margin: auto; } .read-more-background { background: linear-gradient(180deg, color(display-p3 1.000 1.000 1.000 / 0) 13.75%, color(display-p3 1.000 1.000 1.000 / 0.8) 30.79%, color(display-p3 1.000 1.000 1.000) 72.5%); position: absolute; height: 200px; width: 100%; bottom: 0; display: flex; justify-content: center; align-items: center; padding: 0; } .read-more-background a{ color: #000; } .read-more-btn { padding: 17px 45px; font-family: Inter; font-weight: 700; font-size: 18px; line-height: 16px; text-align: center; vertical-align: middle; border: 1px solid black; background-color: white; } .hidden { display: none; }
function initializeAllSwipers() { // Get all hidden inputs with cms_article_id document.querySelectorAll('[id^="cms_article_id_"]').forEach(function (input) { const cmsArticleId = input.value; const articleSelector = '#article-' + cmsArticleId + ' .body_images'; const swiperElement = document.querySelector(articleSelector); if (swiperElement && !swiperElement.classList.contains('swiper-initialized')) { new Swiper(articleSelector, { loop: true, pagination: false, navigation: { nextEl: '#article-' + cmsArticleId + ' .swiper-button-next', prevEl: '#article-' + cmsArticleId + ' .swiper-button-prev', }, }); } }); } setTimeout(initializeAllSwipers, 3000); const intersectionObserver = new IntersectionObserver( (entries) => { entries.forEach((entry) => { if (entry.isIntersecting) { const newUrl = entry.target.getAttribute("data-url"); if (newUrl) { history.pushState(null, null, newUrl); let article = entry.target; // Extract metadata const author = article.querySelector('.author-section').textContent.replace('By', '').trim(); const section = article.querySelector('.section-info ').textContent.replace(' ', ' '); const title = article.querySelector('.article-title h1').textContent; // Parse URL for Chartbeat path format const parsedUrl = new URL(newUrl, window.location.origin); const cleanUrl = parsedUrl.host + parsedUrl.pathname; // Update Chartbeat configuration if (typeof window._sf_async_config !== 'undefined') { window._sf_async_config.path = cleanUrl; window._sf_async_config.sections = section; window._sf_async_config.authors = author; } // Track virtual page view with Chartbeat if (typeof pSUPERFLY !== 'undefined' && typeof pSUPERFLY.virtualPage === 'function') { try { pSUPERFLY.virtualPage({ path: cleanUrl, title: title, sections: section, authors: author }); } catch (error) { console.error('ping error', error); } } // Optional: Update document title if (title && title !== document.title) { document.title = title; } } } }); }, { threshold: 0.1 } ); function showArticleBody(button) { const article = button.closest("article"); const summary = article.querySelector(".article-body-summary"); const body = article.querySelector(".article-body-preview"); const readMoreSection = article.querySelector(".read-more-background"); // Hide summary and read-more section summary.style.display = "none"; readMoreSection.style.display = "none"; // Show the full article body body.classList.remove("hidden"); } document.addEventListener("DOMContentLoaded", () => { let loadCount = 0; // Track how many times articles are loaded const offset = [1, 2, 3, 4, 5, 6, 7, 8, 9, 10]; // Offset values const currentUrl = window.location.pathname.substring(1); let isLoading = false; // Prevent multiple calls if (!currentUrl) { console.log("Current URL is invalid."); return; } const sentinel = document.getElementById("load-more-sentinel"); if (!sentinel) { console.log("Sentinel element not found."); return; } function isSentinelVisible() { const rect = sentinel.getBoundingClientRect(); return ( rect.top < window.innerHeight && rect.bottom >= 0 ); } function onScroll() { if (isLoading) return; if (isSentinelVisible()) { if (loadCount >= offset.length) { console.log("Maximum load attempts reached."); window.removeEventListener("scroll", onScroll); return; } isLoading = true; const currentOffset = offset[loadCount]; window.loadMoreItems().then(() => { let article = document.querySelector('#widget_1690 > div:nth-last-of-type(2) article'); intersectionObserver.observe(article) loadCount++; }).catch(error => { console.error("Error loading more items:", error); }).finally(() => { isLoading = false; }); } } window.addEventListener("scroll", onScroll); });
Join Our Newsletters

Sign up by email to receive news.

© 2025 Manila Bulletin The Nation's Leading Newspaper. All Rights Reserved.